CLINICAL_TRIALS
trial_result
· 2022-03-14
Clinical Trial Update: Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer [Phase 2]
Summary
Phase 2 safety study of nivolumab in advanced or metastatic non-small cell lung cancer completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-03-14